Deucravacitinib: the first FDA-approved oral TYK2 inhibitor for moderate to severe plaque psoriasis
Objective The objective of this study was to review the safety and efficacy of deucravacitinib,
a tyrosine kinase 2 (TYK2) inhibitor for moderate to severe plaque psoriasis. Data Sources …
a tyrosine kinase 2 (TYK2) inhibitor for moderate to severe plaque psoriasis. Data Sources …
[HTML][HTML] Keratolytics and emollients and their role in the therapy of psoriasis: a systematic review
A Jacobi, A Mayer, M Augustin - Dermatology and therapy, 2015 - Springer
Introduction Psoriasis is a common chronic disease with significant impairment in quality of
life. As there is no cure, it often requires lifelong disease control to minimize the …
life. As there is no cure, it often requires lifelong disease control to minimize the …
Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy
CA Elmets, HW Lim, B Stoff, C Connor… - Journal of the American …, 2019 - Elsevier
Psoriasis is a chronic inflammatory disease involving multiple organ systems and affecting
approximately 3.2% of the world's population. In this section of the guidelines of care for …
approximately 3.2% of the world's population. In this section of the guidelines of care for …
[HTML][HTML] Pilot study of folate status in healthy volunteers and in patients with psoriasis before and after UV exposure
A Juzeniene, KT Stokke, P Thune, J Moan - Journal of Photochemistry and …, 2010 - Elsevier
Ultraviolet radiation, UV, is widely used for treatment of psoriasis. UV radiation may destroy
blood folates in test tubes, but clinical data are scarce. Folate deficiency may increase the …
blood folates in test tubes, but clinical data are scarce. Folate deficiency may increase the …
[HTML][HTML] Real-life effectiveness of apremilast for the treatment of psoriasis in Belgium: results from the observational OTELO study
PD Ghislain, J Lambert, XLL Hoai, T Hillary… - Advances in …, 2022 - Springer
Introduction Apremilast is approved for the treatment of psoriasis and psoriatic arthritis.
However, data on the efficacy and safety of apremilast in clinical practice are limited. We …
However, data on the efficacy and safety of apremilast in clinical practice are limited. We …
Plants and plant products with potential antipsoriatic activity–A review
A Kaur, S Kumar - Pharmaceutical biology, 2012 - Taylor & Francis
Context: Psoriasis vulgaris is a hyper proliferative, autoimmune skin disorder affecting 1–3%
of the world's population. The prescribed synthetic drugs for the treatment of psoriasis are …
of the world's population. The prescribed synthetic drugs for the treatment of psoriasis are …
Análise dos medicamentos fornecidos por mandado judicial na Comarca do Rio de Janeiro: a aplicação de evidências científicas no processo de tomada de decisão
TA Figueiredo - 2010 - arca.fiocruz.br
A lei brasileira garante o direito à Assistência Farmacêutica, mas ainda há falhas do Estado
na efetivação do acesso dos cidadãos aos medicamentos, assim, as ações judiciais de …
na efetivação do acesso dos cidadãos aos medicamentos, assim, as ações judiciais de …
[HTML][HTML] Fish oil supplements for treatment of psoriasis: An overview of systematic reviews
HC Chen, YC Kuo, CC Tai, CC Chi - Dermatologica Sinica, 2024 - journals.lww.com
Background: Fish oil, known for its anti-inflammatory and immunomodulatory properties, has
been reported to alleviate psoriasis symptoms. However, systematic reviews (SRs) on this …
been reported to alleviate psoriasis symptoms. However, systematic reviews (SRs) on this …
Most systematic reviews of high methodological quality on psoriasis interventions are classified as high risk of bias using ROBIS tool
F Gómez-García, J Ruano, J Gay-Mimbrera… - Journal of Clinical …, 2017 - Elsevier
Objectives No gold standard exists to assess methodological quality of systematic reviews
(SRs). Although Assessing the Methodological Quality of Systematic Reviews (AMSTAR) is …
(SRs). Although Assessing the Methodological Quality of Systematic Reviews (AMSTAR) is …
Sulphurous medicinal waters increase somatostatin release: It is a possible mechanism of anti-inflammatory effect of balneotherapy in psoriasis
M Boros, Á Kemény, B Sebők, T Bagoly… - European Journal of …, 2013 - Elsevier
AIM: Balneotherapy has been used in the treatment of immune-mediated skin diseases, but
its molecular mechanism has yet to be elucidated. The aim of the present study was to …
its molecular mechanism has yet to be elucidated. The aim of the present study was to …